Skip to main content
. 2018 Feb 12;92(5):e01822-17. doi: 10.1128/JVI.01822-17

FIG 1.

FIG 1

Acute-phase CD8TL responses against the Nef195-203MW9 epitope. Peptide representing the Nef195-203MW9 epitope was used at 0.01 mM to stimulate PBMC from six RM from 4 and 8 weeks postinfection. Overnight stimulations of 100,000 cells per well were tested in duplicate and followed by spot development and counting. Data shown represent the SFC per million PBMC.